SCHEMBL25864310

SCHEMBL25864310

COC1(C)CC(Nc2nnc(-c3ccc(C#CC(F)(F)F)cc3O)c3ccccc23)C1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.42
IL1B P01584 8/20 0.38
TNF P01375 2/20 0.38
KCNH2 Q12809 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
USP2 O75604 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
CHEK1 O14757 1/20 0.30
CHEK2 O96017 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25864311 0.91 NLRP3 (0.44) NLRP3IL1BTNFKCNH2KDM4E
SCHEMBL25855659 0.90 NLRP3 (0.53) NLRP3IL1BTNFKCNH2KDM4E
SCHEMBL25864312 0.90 NLRP3 (0.44) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864313 0.89 NLRP3 (0.44) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864309 0.88 NLRP3 (0.42) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864308 0.88 NLRP3 (0.42) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864305 0.87 NLRP3 (0.42) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864306 0.87 NLRP3 (0.42) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864314 0.87 NLRP3 (0.42) NLRP3IL1BTNFKDM4EHSD17B10
SCHEMBL25864323 0.82 NLRP3 (0.42) NLRP3IL1BTNFKCNH2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131277-A1 NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF 药捷安康(南京)科技股份有限公司 2023-07-13 WO disclosed